🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
The purpose of Phase 1b of the study is to determine the maximum tolerated ...
Status
Withdrawn
Location
Lahey Hospital & Medical Center
Start Date
2014-12
Trial ID
NCT02227914
To evaluate the safety and tolerability of Oprozomib in patients with advan...
Status
Completed
Location
Oncology Research Associates
Start Date
2010-04
Trial ID
NCT01129349
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD),...
Status
Terminated
Location
Mayo Clinic Scottsdale
Start Date
2011-10-15
Trial ID
NCT01416428
Treatments Being Tested
The purpose of Phase 1b of the study is to determine the maximum tolerated ...
Status
Completed
Location
Department of Clinical Therapeutics, University of Athens
Start Date
2014-01
Trial ID
NCT02072863
Treatments Being Tested
A study evaluating two new formulations of oprozomib plus pomalidomide and ...
Status
Completed
Location
Research Site
Start Date
2017-01-17
Trial ID
NCT02939183
Treatments Being Tested
The primary objectives are: Phase 1b: * To determine the maximum tolerate...
Status
Terminated
Location
USC/Norris Comprehensive Cancer Center
Start Date
2013-07-02
Trial ID
NCT01832727
Treatments Being Tested
The primary objectives of this study included the following: Phase 1b: * ...
Status
Terminated
Location
Clearview Cancer Institute
Start Date
2013-10-28
Trial ID
NCT01881789
Treatments Being Tested
The purpose of this Phase 1 of the study is to evaluate the effect of food ...
Status
Terminated
Location
University of Colorado Anschutz Medical Campus
Start Date
2014-08
Trial ID
NCT02244112